Preventive effect of greater occipital nerve block on patients with episodic migraine: A randomized double‐blind placebo‐controlled clinical trial

1. Stovner, LJ, Nichols, E, Steiner, TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 954–976.
Google Scholar | Crossref | Medline2. Robbins, MS. Diagnosis and management of headache: a review. JAMA 2021; 325: 1874–1885.
Google Scholar | Crossref | Medline3. Ashina, M. Migraine. N Engl J Med 2020; 383: 1866–1876.
Google Scholar | Crossref | Medline4. Young, WB. Blocking the greater occipital nerve: utility in headache management. Curr Pain Headache Rep 2010; 14: 404–408.
Google Scholar | Crossref | Medline | ISI5. Inan, N, Inan, LE, Coşkun, Ö, et al. Effectiveness of greater occipital nerve blocks in migraine prophylaxis. Noro psikiyatri arsivi 2016; 53: 45–48.
Google Scholar | Crossref | Medline6. Terzi, T, Karakurum, B, Üçler, S, et al. Greater occipital nerve blockade in migraine, tension-type headache and cervicogenic headache. J Headache Pain 2002; 3: 137–141.
Google Scholar | Crossref7. Afridi, SK, Shields, KG, Bhola, R, et al. Greater occipital nerve injection in primary headache syndromes–prolonged effects from a single injection. Pain 2006; 122: 126–129.
Google Scholar | Crossref | Medline | ISI8. Gawel, MJ, Rothbart, PJ. Occipital nerve block in the management of headache and cervical pain. Cephalalgia 1992; 12: 9–13.
Google Scholar | SAGE Journals | ISI9. Charles, A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol 2018; 17: 174–182.
Google Scholar | Crossref | Medline10. Piovesan, EJ, Di Stani, F, Kowacs, PA, et al. Massaging over the greater occipital nerve reduces the intensity of migraine attacks: evidence for inhibitory trigemino-cervical convergence mechanisms. Arq Neuropsiquiatr 2007; 65: 599–604.
Google Scholar | Crossref | Medline11. Goadsby, PJ, Knight, YE, Hoskin, KL. Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. PAIN 1997; 73: 23–28.
Google Scholar | Crossref | Medline12. Caputi, CA, Firetto, V. Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients. Headache 1997; 37: 174–179.
Google Scholar | Crossref | Medline | ISI13. Okmen, K, Dagistan, Y, Dagistan, E, et al. Efficacy of the greater occipital nerve block in recurrent migraine type headaches. Neurol Neurochir Pol 2016; 50: 151–154.
Google Scholar | Crossref | Medline14. Rodrigo, D, Acin, P, Bermejo, P. Occipital nerve stimulation for refractory chronic migraine: results of a long-term prospective study. Pain Physician 2017; 20: E151–E159.
Google Scholar | Crossref | Medline15. Chowdhury, D, Mundra, A. Role of greater occipital nerve block for preventive treatment of chronic migraine: A critical review. Cephalalgia Reports January 2020. doi:10.1177/2515816320964401.
Google Scholar16. Ashkenazi, A, Matro, R, Shaw, JW, et al. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry 2008; 79: 415–417.
Google Scholar | Crossref | Medline | ISI17. Headache Classification Committee of the International Headache S . The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629–808.
Google Scholar | SAGE Journals | ISI18. Olesen, J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1–211.
Google Scholar | SAGE Journals19. Tfelt-Hansen, P, Pascual, J, Ramadan, N, et al. Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators. Cephalalgia 2012; 32: 6–38.
Google Scholar | SAGE Journals | ISI20. Blumenfeld, A, Ashkenazi, A, Napchan, U, et al. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches–a narrative review. Headache 2013; 53: 437–446.
Google Scholar | Crossref | Medline | ISI21. Dilli, E, Halker, R, Vargas, B, et al. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study. Cephalalgia 2015; 35: 959–968.
Google Scholar | SAGE Journals | ISI22. Becker, DE, Reed, KL. Local anesthetics: review of pharmacological considerations. Anesth Prog 2012; 59: 90–101.
Google Scholar | Crossref | Medline23. Shauly, O, Gould, DJ, Sahai-Srivastava, S, et al. Greater occipital nerve block for the treatment of chronic migraine headaches: a systematic review and meta-analysis. Plastic Reconstr Surg 2019; 144: 943–952.
Google Scholar | Crossref | Medline24. Gul, HL, Ozon, AO, Karadas, O, Koc, G, Inan, LE. The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study. Acta neurologica Scandinavica 2017; 136: 138–144.
Google Scholar | Crossref | Medline25. Inan, LE, Inan, N, Karadaş, Ö, et al. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study. Acta Neurol Scand 2015; 132: 270–277.
Google Scholar | Crossref | Medline | ISI26. Palamar, D, Uluduz, D, Saip, S, et al. Ultrasound-guided greater occipital nerve block: An efficient technique in chronic refractory migraine without aura? Pain Physician 2014; 18: 153–162.
Google Scholar27. Diener, HC. Placebo effects in treating migraine and other headaches. Curr Opin Investig Drugs 2010; 11: 735–739.
Google Scholar | Medline28. Mørch, CD, Hu, JW, Arendt-Nielsen, L, et al. Convergence of cutaneous, musculoskeletal, dural and visceral afferents onto nociceptive neurons in the first cervical dorsal horn. Eur J Neurosci 2007; 26: 142–154.
Google Scholar | Crossref | Medline | ISI29. Roberson, DP, Binshtok, AM, Blasl, F, et al. Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review. Br J Pharmacol 2011; 164: 48–58.
Google Scholar | Crossref | Medline30. Bartsch, T, Goadsby, PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Curr Pain Headache Rep 2003; 7: 371–376.
Google Scholar | Crossref | Medline31. Lambru, G, Lagrata, S, Matharu, MS. Cutaneous atrophy and alopecia after greater occipital nerve injection using triamcinolone. Headache 2012; 52: 1596–1599.
Google Scholar | Crossref | Medline | ISI32. Shields, KG, Levy, MJ, Goadsby, PJ. Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid. Neurology 2004; 63: 2193–2194.
Google Scholar | Crossref | Medline | ISI33. Schetman, D, Hambrick Jr GW, Wilson, CE. Cutaneous changes following local injection of triamcinolone. Arch Dermatol 1963; 88: 820–828.
Google Scholar | Crossref | Medline34. Kashipazha, D, Nakhostin-Mortazavi, A, Mohammadianinejad, SE, et al. Preventive effect of greater occipital nerve block on severity and frequency of migraine headache. Global J Health Sci 2014; 6: 209–213.
Google Scholar | Crossref | Medline35. Diener, HC, Tassorelli, C, Dodick, DW, et al. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia 2020; 40: 1026–1044.
Google Scholar | SAGE Journals | ISI

留言 (0)

沒有登入
gif